PSI/PORT Score: Pneumonia Severity Index for CAP

Risk stratification of community-acquired pneumonia to help determine inpatient versus outpatient treatment.

Audience: PRACTITIONER

Published by EVAL Foundation

Revision 3 · Published August 6, 2024

Summary

Usage

Community acquired pneumonia (CAP) is a common condition that presents in the outpatient setting (primary care and emergency care) with a hospitalization rate of approximately 2% in ages ≥ 65 years and is associated with a 30-day mortality rate of 5% in hospitalized patients (Womack & Kropa, 2022). Further, Womack & Kropa highlight that in 11% of patients a bacterial pathogen was identified, 23% of patients a viral pathogen and 62% of patients no organism was identified. (Note: These studies were conducted before the COVID-19 pandemic.) Diagnosis of community acquired pneumonia (CAP) is usually made with a combination of history, physical exam, and findings on chest x-ray, lung US or chest CT scan. Clinicians are encouraged to use both their clinical judgement and a validated clinical prediction rule to determine the need for hospitalization in patients with CAP (Armstrong, 2020). The Pneumonia Severity (PSI) Pneumonia Patient Outcomes Research Team (PORT) prediction rule is a well-validated risk stratification tool that can assist clinicians in the outpatient setting with determining disposition (inpatient versus outpatient). 

 

However, validated clinical prediction rules, like the PSI/PORT and CURB-65, do not effectively determine the level of care required (Armstrong, 2020). The American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA) criteria for severe CAP is preferred to predict ICU admission.¹ Low-quality evidence suggests the PSI/PORT may outperform CURB-65. Armstrong (2020) reports the PSI/PORT can underestimate the severity of illness among younger patients, but it has higher discriminative power in predicting mortality and a lover false-positive rate then the CURB-65.

 

¹Statement on COVID-19 (Armstrong, 2020): "Editor's Note: This ATS/IDSA guideline was produced before the COVID-19 pandemic, which has altered the diagnosis and management of lower respiratory tract infections. The current version of this guideline limits testing and antiviral treatment in patients with influenza, and we expect testing for and treatment of severe acute respiratory syndrome coronavirus 2 infection to become a long-standing element of standard pneumonia care. 

.

Summary

The Pneumonia Severity (PSI) Pneumonia Patient Outcomes Research Team (PORT) prediction rule is a well-validated risk stratification tool that can assist clinicians in the outpatient setting with determining disposition (inpatient versus outpatient). Diagnosis of community acquired pneumonia (CAP) is usually made with a combination of history, physical exam, and findings on chest x-ray, lung US or chest CT scan. Intended for immunocompetent adults who have not recently traveled internationally.

 

 

Rule criteria

 

CriteriaPoints
Age1 point per year
SexMale (0) Female (-10)
Nursing home resident10
Neoplastic disease¹30
Liver disease history²20
Cerebrovascular disease history³10
Renal disease history⁴10
Liver disease history⁵20
Altered mental status⁶20
Pulse ≥ 125 beats/min10
Respiratory rate ≥ 30 breaths/min20
Systolic blood pressure < 90 mmHg20
Temperature < 35°C (95°F) or > 39.9°C (103.8°F)15
Pleural effusion on x-ray10
pH < 7.3530
BUN ≥ 30 mg/dL or ≥ 11 mmol/L20
Sodium < 130 mmol/L20
Glucose ≥ 250 mg/dL or ≥ 14 mmol/L10
Hematocrit < 30%10
Partial pressure of oxygen < 60 mmHg or < 8 kPa⁷10

 

¹Defined as any cancer (except basal- or squamous-cell cancer of the skin) that was active at the time of presentation or diagnosed within one year of presentation.

²Defined as a clinical or histologic diagnosis of cirrhosis or another form of chronic liver disease, such as chronic active hepatitis.

³Defined as a clinical diagnosis of stroke or transient ischemic attack or stroke documented by MRI or CT.

⁴Defined as a history of chronic renal disease or abnormal blood urea nitrogen and creatinine concentrations documented in the medical record.

⁵Defined as a clinical or histologic diagnosis of cirrhosis or another form of chronic liver disease, such as chronic active hepatitis.

⁶Defined as disorientation with respect to person, place, or time that is not known to be chronic, stupor, or coma.

⁷In the Pneumonia PORT cohort study, an oxygen saturation of < 90% on pulse oximetry or intubation before admission was also considered abnormal.

 

 

Scoring & Recommendations 

 

The following 11 criteria or risk factors are presented first:

 

If age is < 51 and the following 10 criteria are "no," then the remaining risk criteria will not be asked, no score is calculated, and the patient is assigned class I which is consistent with the original PORT design study by Fine et al (1997).

 

RecommendationCriteriaPoints

Class I: Outpatient care with oral antibiotics

Low Risk: 0.1% mortality risk

  • Age < 51
  • No neoplastic disease
  • No CHF history
  • No cerebrovascular history
  • No renal disease history
  • No liver disease history
  • No altered mental status
  • No pulse ≥ 125 beats/min
  • No Respiratory rate ≥ 30 breaths/min
  • No Systolic blood pressure < 90 mmHg
  • No Temperature < 35°C (95°F) or > 39.9°C (103.8°F)
No points 

Class II: Outpatient care with oral antibiotics 

Low Risk: 0.6-0.9% mortality

  • Does not meet Class I criteria
  • Score ≤ 70
≤ 70

Class III: Outpatient or inpatient admission 

Low Risk: 0.9-2.8% mortality

  • Does not meet Class I criteria
  • Score 71-90
71-90

Class IV: Inpatient admission 

Moderate Risk: 8.2-9.3% mortality

  • Does not meet Class I criteria
  • Score 91-130
91-130

Class V: Inpatient admission 

High Risk: 27.0-29.2% mortality

  • Does not meet Class I criteria
  • Score > 130
> 130

 

 

Considerations

According to the American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA) practice guidelines on patients with community acquired pneumonia (CAP)(Armstrong, 2020; Womack & Kropa, 2022):

 

¹Statement on COVID-19 (Armstrong, 2020): "Editor's Note: This ATS/IDSA guideline was produced before the COVID-19 pandemic, which has altered the diagnosis and management of lower respiratory tract infections. The current version of this guideline limits testing and antiviral treatment in patients with influenza, and we expect testing for and treatment of severe acute respiratory syndrome coronavirus 2 infection to become a long-standing element of standard pneumonia care. 

.

Instructions

 

 

 

Tags

Literature

Contributors

Revisions

Current: Revision 3

About this evaluation